InterVenn Biosciences: Joshua Stahl

Sep 28, 2023

InterVenn Biosciences has appointed Joshua Stahl as CEO. Stahl was previously CSO and chief operating officer at ArcherDx. Following ArcherDx's acquisition by Invitae in 2020, he served as president of oncology of that company.